Truist Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,339
| Closed | -$688K | – | 2823 |
|
|
2021
Q3 | $688K | Sell |
12,339
-29
| -0.2% | -$1.62K | ﹤0.01% | 1811 |
|
|
2021
Q2 | $529K | Sell |
12,368
-12
| -0.1% | -$513 | ﹤0.01% | 1984 |
|
|
2021
Q1 | $517K | Buy |
12,380
+24
| +0.2% | +$1K | ﹤0.01% | 1933 |
|
|
2020
Q4 | $575K | Sell |
12,356
-6,101
| -33% | -$284K | ﹤0.01% | 1769 |
|
|
2020
Q3 | $784K | Buy |
18,457
+56
| +0.3% | +$2.38K | ﹤0.01% | 1466 |
|
|
2020
Q2 | $883K | Buy |
18,401
+8
| +0% | +$384 | ﹤0.01% | 1337 |
|
|
2020
Q1 | $846K | Buy |
18,393
+16
| +0.1% | +$736 | ﹤0.01% | 1310 |
|
|
2019
Q4 | $1.1M | Buy |
+18,377
| New | +$1.1M | ﹤0.01% | 1378 |
|